CHA₂DS₂-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation

详细信息    查看全文

• 作者：Bartosz Hudzik ; Janusz Szkodziński ; Michal Hawranek ; Andrzej Lekston…
• 关键词：STEMI ; Diabetes mellitus ; Risk score ; CHA2DS2 ; VASc ; Prognosis
• 刊名：Acta Diabetologica
• 出版年：2016
• 出版时间：October 2016
• 年：2016
• 卷：53
• 期：5
• 页码：807-815
• 全文大小：692 KB
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Internal Medicine
  Diabetes
  Metabolic Diseases
  
• 出版者：Springer Milan
• ISSN：1432-5233
• 卷排序：53

文摘

AimsTIMI risk score and GRACE risk model are widely available and accepted scores for risk assessment in STEMI patients and include predictors of poor outcomes. CHA₂DS₂-VASc is a validated score for predicting embolic/stroke risk in patients with non-valvular atrial fibrillation. Its components contribute to the worse prognosis following myocardial infarction. The advantage of the CHA₂DS₂-VASc score in comparison with other risk scores is that it provides a comprehensive, fast, and simple method for physicians in risk evaluation that requires no calculators or computers. Therefore, we have set out to examine the prognostic significance of CHA₂DS₂-VASc score following STEMI in diabetic patients without AF.